Premium
P18: Samatasvir (IDX719), a potent pan‐genotypic HCV NS5A inhibitor
Author(s) -
Mayers D
Publication year - 2013
Publication title -
journal of viral hepatitis
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.12166_17
Subject(s) - tolerability , placebo , viral load , medicine , hepatitis c virus , pharmacodynamics , pharmacokinetics , gastroenterology , genotype , ns5a , randomized controlled trial , pharmacology , virology , hepacivirus , adverse effect , virus , biology , pathology , biochemistry , alternative medicine , gene